Cargando…
Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase
Diabetic nephropathy (DN) is among the most common complications of diabetes mellitus. The disorder is associated with a decrease in the activity of the nitric oxide synthase/nitric oxide system. Piperazine ferulate (PF) is widely used for the treatment of kidney disease in China. The aim of the pre...
Autores principales: | Yang, Yong-Yu, Shi, Ling-Xing, Li, Jian-He, Yao, Liang-Yuan, Xiang, Da-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390022/ https://www.ncbi.nlm.nih.gov/pubmed/30664213 http://dx.doi.org/10.3892/mmr.2019.9875 |
Ejemplares similares
-
Piperazine ferulate prevents high-glucose-induced filtration barrier injury of glomerular endothelial cells
por: Yang, Yong-Yu, et al.
Publicado: (2021) -
Homoarginine ameliorates diabetic nephropathy independent of nitric oxide synthase‐3
por: Wetzel, Michael D., et al.
Publicado: (2021) -
Ferulic acid modulates nitric oxide synthase expression in focal cerebral ischemia
por: Koh, Phil-Ok
Publicado: (2012) -
Piperazine ferulate attenuates high glucose-induced mesangial cell injury via the regulation of p66(Shc)
por: Yang, Yong-Yu, et al.
Publicado: (2021) -
Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy
por: Satoh, Minoru, et al.
Publicado: (2008)